Homology Medicines Inc
NASDAQ:QTTB
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Homology Medicines Inc
NASDAQ:QTTB
|
US |
|
A
|
Aspen Pharmacare Holdings Ltd
SWB:LDZA
|
ZA |
|
A
|
Aramark
F:0AK
|
US |
|
M
|
Molson Coors Beverage Co
LSE:0K2K
|
US |
|
Y
|
Yext Inc
SWB:0YE
|
US |
|
T
|
Ternium SA
F:T5Z
|
LU |
|
P
|
Precigen Inc
F:I5X
|
US |
|
T
|
Takashimaya Co Ltd
DUS:TKM
|
JP |
|
I
|
Ichikoh Industries Ltd
F:7P0
|
JP |
|
G
|
Grifols SA
SWB:OZTA
|
ES |
|
Exxaro Resources Ltd
OTC:EXXAF
|
ZA |
|
G
|
GomSpace Group AB
STO:GOMX
|
SE |
Wall St Price Targets
QTTB Price Targets Summary
Homology Medicines Inc
According to Wall Street analysts, the average 1-year price target for
QTTB is 14.54 USD with a low forecast of 10.1 USD and a high forecast of 21 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is QTTB's stock price target?
Price Target
14.54
USD
According to Wall Street analysts, the average 1-year price target for
QTTB is 14.54 USD with a low forecast of 10.1 USD and a high forecast of 21 USD.